Baked Milk Oral Immunotherapy Found to be Effective Treatment for Cow's Milk Allergy
Research shows after 12 and 24 months of treatment, participants experienced significant desensitization to milk products MILWAUKEE, Feb. 7, 2024 /PRNewswire-PRWeb/ -- Baked milk oral immunotherapy (BMOIT) is well tolerated and induces substantial desensitization to both baked and... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 7, 2024 Category: Pharmaceuticals Tags: TRI FVT CHI Source Type: news
Shielding From Allergies: It’s Not Just About Microbes
Clean and dirty mice respond similarly to allergens, challenging the idea that reduced microbial exposure is the primary cause behind the uptick in allergies. (Source: The Scientist)
Source: The Scientist - February 7, 2024 Category: Science Tags: News News & Opinion Source Type: news
Health Equity Drives Extension of Exclusive Partnership Between PlatformQ Health and the Asthma and Allergy Foundation of America
The Asthma and Allergy Foundation of America (AAFA) and PlatformQ Health have extended their long-standing collaboration for another three years to continue bringing trusted digital education to those affected by asthma and related conditions. BOSTON, Feb. 7, 2024 /PRNewswire-PRWeb/ --... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 7, 2024 Category: Pharmaceuticals Tags: LIC Source Type: news
Anima Biotech Announces Preclinical Data of Candidate in Idiopathic Pulmonary Fibrosis
BERNARDSVILLE, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, announced today positive preclinical data of its lung fibrosis candidate. This drug operates through a novel mRNA biology mechanism of action, opening new avenues for treating…#bernardsville #animabiotech #ipf #lightningplatform #anima #admet #yochislonim #abbvie #elililly #immunologyoncology (Source: Reuters: Health)
Source: Reuters: Health - February 7, 2024 Category: Consumer Health News Source Type: news
RNA Vaccines: Risk for Heavy Menstrual Bleeding Clarified RNA Vaccines: Risk for Heavy Menstrual Bleeding Clarified
Compared with controls, women with heavy menstrual bleeding were more likely to have received their last dose of mRNA vaccine in the previous 1-3 months in a recent study.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 7, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
